Glutamatergic System and Neuroimaging Studies of Treatment-Resistant Schizophrenia

Affiliations

¹ Psychotic Disorders Division, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. Electronic address: vchouinard@mclean.harvard.edu.

Comment

Virginie-Anne Chouinard. Biol Psychiatry. 2019.

. 2019 Apr 1;85(7):e31-e32.

doi: 10.1016/j.biopsych.2019.02.003.

¹ Psychotic Disorders Division, McLean Hospital, Belmont, Massachusetts; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts. Electronic address: vchouinard@mclean.harvard.edu.

No abstract available

Comment on

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study.
Iwata Y, Nakajima S, Plitman E, Caravaggio F, Kim J, Shah P, Mar W, Chavez S, De Luca V, Mimura M, Remington G, Gerretsen P, Graff-Guerrero A. Iwata Y, et al. Biol Psychiatry. 2019 Apr 1;85(7):596-605. doi: 10.1016/j.biopsych.2018.09.009. Epub 2018 Sep 26. Biol Psychiatry. 2019. PMID: 30389132